Back to search

Article

Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer

2023-07-17

Abstract excerpt

<h4>Background: </h4> About 30% of Prostate cancer (PCa) patients progress to metastatic PCa that remains largely incurable. This evidence underlines the need for the development of innovative therapies. In this direction, the potential research focus might be on long non-coding RNAs (lncRNAs) like H19, which serve critical biological functions and show significant dysregulation in cancer. Previously, it has been...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cc950364-c815-5561-9877-36dec19f4498
DOI
10.21203/rs.3.rs-3149557/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancerDOI 10.21203/rs.3.rs-3149557/v1
Select a neighboring publication to make it the new centre.